AIM
AIM ImmunoTech
14 hedge funds and large institutions have $1.38M invested in AIM ImmunoTech in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$269K | |
| 2 | +$22K | |
| 3 | +$11.9K | |
| 4 |
Bank of New York Mellon
New York
|
+$9K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.29K |
Top Sellers
| 1 | -$739K | |
| 2 | -$120K | |
| 3 | -$9.78K | |
| 4 |
Renaissance Technologies
New York
|
-$4.87K |